RENO, Nev., Sept. 19, 2019 /PRNewswire/ — The Orthopaedic Implant Company (“OIC”) has announced their participation in a pilot program led by Intermountain Healthcare, which has resulted in $3.6 million reduction on supply expenses so far. While patients appreciate the value, Intermountain’s overall strategy is designed to have more of a macroeconomic impact, lowering insurance premiums for people in the communities it serves.

“Intermountain Healthcare is nationally known for maintaining the highest standards of care and is clearly working toward their vision of providing extraordinary care and superior service at an affordable cost.  The future of US Healthcare can only be successful if we continue to strive for optimal outcomes while greatly improving value. IHC understands that,” said Itai Nemovicher, President and CEO, at OIC.  “We have a unique model that flourishes in systems where surgeons and administration work together in controlling costs. This has been a cornerstone of our partnership with this progressive-thinking IDN.”

Intermountain leaders credit, in part, the success of the program to the surgeons who involved themselves in the process, assisting in making decisions and working with reps on discounts that complied with the program.